Sensigen Options Rights to Lupus Dx Biomarkers from Univ. of Michigan

Jul 13, 2007

NEW YORK (GenomeWeb News) — Sensigen has acquired an option from the University of Michigan to exclusively license a set of epigenetic biomarkers that can detect and monitor lupus, the company said this week.

The technology covered under the license is a panel of biomarkers of epigenetic variations of genes and related research assays linked to lupus, the company said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

New Framework Suggested

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

Penguins With Roving Eyes

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Funding Lost

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

This Week in Science

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

Main menu